Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07a61391e48815701d98243c8d8c6bdf |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 |
filingDate |
2007-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10ed4795a0a6974c8b009338b2c6c976 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c633df860aa6916a9eb0c2143d68c61b |
publicationDate |
2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2379113-T3 |
titleOfInvention |
Anti-inflammatory fusion protein |
abstract |
Fusion protein that has: (a) a first polypeptide that specifically binds to oxidized LDL (oxLDL), and (b) a second polypeptide that mediates dimerization, characterized in that the first polypeptide has a segment or a variant of CD68 sequence , which respectively present the LDL binding function of CD68. |
priorityDate |
2006-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |